hypoxia in newborn piglets . oxide in pulmonary hypertension induced by Effects of magnesium sulphate and nitric
C. Ryan,N. Finer,K. Barrington
Abstract:Aim-To examine the haemodynamic effects of intravenous magnesium sulphate on an animal model of neonatal pulmonary hypertension induced by hypoxia. Methods-The cardiac index (Q), pulmonary arterial pressure (PAP), systemic arterial pressure (SAP), and pulmonary (PVRI) and systemic (SVRI) vascular resistance indices were measured in nine newborn piglets (including three controls). Pulmonary hypertension was induced by lowering the FiO2 to 0412-0-144 after which there was a significant increase in PAP and PVRI (37% and 142%, respectively; p<OOl) and a significant fall in SAP and Q (30% and 33%, respectively; p<O*Ol). Results-Magnesium sulphate was infused intravenously as four doses of 25 mg/kg, 15 minutes apart, which resulted in a significant mean (SD) increase in serum magnesium (0-83 (0.07) mmol/l to 1-82 (0-19) mmol/l; p<O-Ol). After the initial dose SAP, SVRI, PAP and PVRI decreased, but not significantly. Each subsequent dose of (50, 75, 100 mg/kg) was accompanied by further significant reductions in these variables from control baseline (p<0 05). The PVRI:SVRI ratio remained unchanged throughout. Inhaled nitric oxide (NO) 40 ppm was administered after the last dose ofmagnesium sulphate. The PVRI:SVRI significantly decreased (p<0.05), indicating that reversible pulmonary hypertension remained after a maximum dose ofmagnesium sulphate. Conclusions-Unlike NO, magnesium sulphate is not a selective pulmonary vasodilator and may lead to deleterious effects on systemic pressures in critically ill newborns. (Arch Dis Child 1994; 71: F151-F155) Persistent pulmonary hypertension of the newbom is characterised by high levels of pulmonary vascular resistance, resulting in right to left shunting across the ductus arteriosus and foramen ovale.1-3 The magnitude of this shunt depends on the ratio of the systemic and pulmonary vascular resistance. Vasodilators, such as nitrates, tolazoline, calcium channel blockers and others, have little potential for directly decreasing shunt across these fetal channels because of non-differential effects on both systemic and pulmonary vascular resistance.46 Magnesium, which has been called nature's calcium blocker,7 antagonises calcium ion entry into smooth muscle cells, thereby promoting vasodilation.8 While it has also been proposed as a possible selective pulmonary vasodilator,9 magnesium sulphate infusion (200 mg/kg) produced a significant fall (34-6%) in mean pulmonary artery pressure (PAP), but also a 37/4% decrease in systemic arterial pressure (SAP) in an adult sheep model of pulmonary hypertension induced by hypoxia. 10 Haemodynamic responses can vary considerably in a young animal compared with a mature animal. The aim of this study, therefore, was to examine the haemodynamic effects of magnesium sulphate at various doses in a newborn pig model of pulmonary hypertension induced by hypoxia and to compare these responses with those seen with the inhalation of nitric oxide (NO), a known selective pulmonary dilator. l l-16 Department of Newborn Medicine, Royal Alexandra Hospitals N N Finer Department of Pediatrics and the Perinatal Research Center, University of Alberta, Edmonton, Alberta, Canada C A Ryan K J Barmngton Correspondence to: Dr Neil N Finer, Royal Alexandra Hospital, 10240 Kingsway, Edmonton, Alberta, Canada T5H 3V9. Accepted 1O June 1994 F151 group.bmj.com on June 17, 2017 Published by http://fn.bmj.com/ Downloaded from